{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:14:15Z","timestamp":1789665255672,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Public Welfare Scientific Research Project of China","award":["201402012"],"award-info":[{"award-number":["201402012"]}]},{"name":"CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW","award":["2016ZX310182-1"],"award-info":[{"award-number":["2016ZX310182-1"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-008"],"award-info":[{"award-number":["2016-I2M-1-008"]}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special","doi-asserted-by":"publisher","award":["2016-2-40114"],"award-info":[{"award-number":["2016-2-40114"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.clim.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:47:00Z","timestamp":1542113220000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts"],"prefix":"10.1016","volume":"198","author":[{"given":"Linqing","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2018.11.008_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.clim.2018.11.008_bb0010","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.autrev.2014.08.023","article-title":"Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study","volume":"13","author":"Danieli","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.clim.2018.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00296-017-3799-x","article-title":"Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain","volume":"37","author":"Nuno-Nuno","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.clim.2018.11.008_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","article-title":"Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease","volume":"194","author":"Johnson","year":"2016","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.clim.2018.11.008_bb0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/s10165-012-0673-2","article-title":"Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease","volume":"23","author":"Woo","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2018.11.008_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.clim.2018.11.008_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.clim.2018.11.008_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","article-title":"The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis","volume":"16","author":"Hoeltzel","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2018.11.008_bb0050","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2018.11.008_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/art.40491","article-title":"Differential clinical associations of anti-nuclear matrix protein-2 autoantibodies in patients with idiopathic inflammatory myopathies","author":"Yang","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2018.11.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-11-223","article-title":"Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis","volume":"11","author":"Kang","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jmii.2014.05.012","article-title":"Detection of anti-p155\/140, anti-p140, and antiendothelial cells autoantibodies in patients with juvenile dermatomyositis","volume":"49","author":"Yu","year":"2016","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0070","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar4207","article-title":"Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara","volume":"15","author":"Petri","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4236\/ojra.2014.42018","article-title":"Clinical phenotype of japanese patients with dermatomyositis\u2014classification based on dermatomyositis-specific autoantibodies","volume":"4","author":"Sato","year":"2014","journal-title":"Open J. Rheumatol. Autoimmune Dis."},{"key":"10.1016\/j.clim.2018.11.008_bb0080","article-title":"Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients","author":"Best","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2018.11.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-018-4216-x","article-title":"Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay","author":"Wang","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2018.11.008_bb0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"36","key":"10.1016\/j.clim.2018.11.008_bb0095","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1556\/650.2015.30221","article-title":"Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients","volume":"156","author":"Bodoki","year":"2015","journal-title":"Orv. Hetil."},{"issue":"11","key":"10.1016\/j.clim.2018.11.008_bb0100","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2018.11.008_bb0105","first-page":"25","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (United States)"},{"issue":"7","key":"10.1016\/j.clim.2018.11.008_bb0110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2013.10416","article-title":"Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis","volume":"150","author":"Valenzuela","year":"2014","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2018.11.008_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","article-title":"Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study","volume":"19","author":"Yang","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.clim.2018.11.008_bb0120","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","article-title":"Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset","volume":"53","author":"Tansley","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2018.11.008_bb0125","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.clim.2018.11.008_bb0130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"11","key":"10.1016\/j.clim.2018.11.008_bb0135","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.clim.2018.11.008_bb0140","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.clim.2018.11.008_bb0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2018.11.008_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.clim.2018.11.008_bb0155","first-page":"652","article-title":"Clinical and serological characterization of the anti-MJ antibody in childhood myositis","volume":"40","author":"Oddis","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0160","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10067-016-3453-0","article-title":"Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis","volume":"36","author":"Ceribelli","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.clim.2018.11.008_bb0170","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2018.11.008_bb0175","first-page":"815","article-title":"Autoantibodies to the p140 autoantigen NXP-2 in adult dermatomyositis","volume":"60","author":"Betteridge","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-016-1704-1","article-title":"Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets","volume":"309","author":"Merlo","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2018.11.008_bb0185","article-title":"Distinctive cutaneous and systemic features associated with specific anti-myositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients","author":"Best","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"24","key":"10.1016\/j.clim.2018.11.008_bb0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MD.0000000000000222","article-title":"Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features","volume":"93","author":"Troyanov","year":"2014","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clim.2018.11.008_bb0195","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2018.11.008_bb0200","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies-anti-TIF1 gamma, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.clim.2018.11.008_bb0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","article-title":"Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2","volume":"51","author":"Ishikawa","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2018.11.008_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex516","article-title":"Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis","author":"Aouizerate","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2018.11.008_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2018.1452353","article-title":"Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies","author":"Ueki","year":"2018","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2018.11.008_bb0220","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/14397595.2014.896494","article-title":"Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients","volume":"24","author":"Kang","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clim.2018.11.008_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir. Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:38:24Z","timestamp":1565260704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618305850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"alternative-id":["S1521661618305850"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734453880.793567632","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}